Safety Study of Cord Blood Units

A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
500 patients (estimated)
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
National Cancer Institute (NCI)
Tags
Allogeneic Stem Cell Transplant, Cord Blood
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
1581
NCT Identifier
NCT01861093

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.